pharmaceutical manufacturing
India doubles down on domestic active pharmaceutical ingredient manufacturing
Centre sets Jan 1 deadline for states to ensure pharma firms meet global norms
Make in India booster: Eli Lilly announces $1 billion investment in country
TN cough syrup samples adulterated; production halted after child deaths in MP, Rajasthan
Celltrion acquires US biopharma plant from Eli Lilly to counter tariff threats
Samsung Biologics signs $1.29 billion deal with US pharma firm
Guj CM Bhupendra Patel reviews progress of Rs 3,920 crore bulk drug park in Jambusar
48 projects approved to avoid disruption in supply of critical active pharma ingredients
Indian CRDMO sector set to touch USD 22-25 billion by 2035: Report